SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-026481
Filing Date
2010-05-06
Accepted
2010-05-06 17:28:49
Documents
7
Period of Report
2010-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-9570_28k.htm 8-K 41557
2 EX-99.1 a10-9570_2ex99d1.htm EX-99.1 46402
3 EX-99.2 a10-9570_2ex99d2.htm EX-99.2 61670
4 EX-99.3 a10-9570_2ex99d3.htm EX-99.3 272372
5 EX-99.4 a10-9570_2ex99d4.htm EX-99.4 11358
6 GRAPHIC g95702moi001.gif GRAPHIC 6754
7 GRAPHIC g95702mmi001.gif GRAPHIC 6754
  Complete submission text file 0001104659-10-026481.txt   454026
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 10809350
SIC: 2834 Pharmaceutical Preparations